Immunome, Inc.

Director, Clinical Site and Trial Operations

Bothell, Washington, United States · Director

Sponsorship not specifiedDetected 20 days ago

GCPComplianceVendor ManagementClinical TrialsFDA RegulatoryLeadershipCollaborationRegulatory Affairs

About the role

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug
conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been submitted to the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-3050, an IND-cleared FAP-targeted radiotherapy; and IM-1617, an IND-cleared solid tumor ADC. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed

Lead site management and trial operations across Immunome's oncology portfolio from planning through completion, ensuring studies meet timelines, budgets, and quality standards.
Build, lead, and mentor a high-performing CSTO team.
Support long-term resource planning and department growth for a rapidly expanding clinical portfolio.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies.
The Director will lead and develop a high-performing CSTO team, partner closely with Clinical Project Delivery on trial delivery, oversee day-to-day vendor management, and establish site-facing best practices to ensure operational excellence.
The Director may also lead one or more outsourced trials and/or lead US site management and trial operations activities on mixed model studies where US site management and monitoring is conducted in-house, and ex-US is outsourced.

Establish a strategic vision for the function and implement operational best practices and SOPs in collaboration with cross-functional teams.
The Director will collaborate with cross-functional stakeholders, including Clinical Development, Regulatory Affairs, Medical Affairs, CMC, and Quality, to ensure the successful execution of Immunome's clinical trials.

We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates.
We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

This listing is sourced directly from Immunome, Inc.'s careers page and normalized into a canonical job model.